Singapore markets open in 17 minutes

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.96+0.68 (+5.54%)
At close: 04:00PM EST
12.90 -0.06 (-0.46%)
After hours: 05:06PM EST
Full screen
Trade prices are not sourced from all markets
Previous close12.28
Bid12.89 x 800
Ask13.98 x 800
Day's range11.85 - 13.08
52-week range9.56 - 31.46
Avg. volume1,057,750
Market cap917.125M
Beta (5Y monthly)1.58
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Shares of Zentalis Pharmaceuticals Dropped This Week

    Shares of Zentalis Pharmaceuticals (NASDAQ: ZNTL) were down 13.5% for the week as of Friday afternoon, according to data provided by S&P Global Market Intelligence. The stock's prices were likely driven down by lowered investor sentiment due to a rash of insider selling. Zentalis is a clinical-stage biotech company that focuses on small-molecule therapies to treat cancer, specifically cancers with broad patient populations.

  • Zacks

    Wall Street Analysts Believe Zentalis Pharmaceuticals, Inc. (ZNTL) Could Rally 95.67%: Here's is How to Trade

    The consensus price target hints at a 95.7% upside potential for Zentalis Pharmaceuticals, Inc. (ZNTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.